RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in ...

Investor Martin Shkreli's big biotech short position is blowing up after the stock's monumental rally over the past week.

Pfizer’s VC arm has backed a $100 million series A raise for OTR Therapeutics, as the Chinese biotech tacks on preclinical ...

Shares of Regeneron Pharmaceuticals ( REGN 0.56%), a biotech giant, have been southbound over the past two years as the ...

The George Soros protege has generated legendary returns for decades, so it's hard not to take stock in where Druckenmiller ...

Most AI drug development is fueled by foundation models in biology—models that are trained on vast biological data sets and ...

The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies ...

China's Sichuan Kelun-Biotech Biopharmaceutical (6990.HK) said Thursday night it would license an experimental cancer ...

Legend Biotech (LEGN) announced new long-term clinical and translational data for CARVYKTI from the CARTITUDE-1 and CARTITUDE-4 studies in ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.